Overview
Leukapheresis is performed on normal donors using Institutional Review Board (IRB)-approved consent forms and protocols. Approximately two to three blood volumes are processed using the Spectra Optia® Apheresis System (unless otherwise requested) to produce a full-sized leukopak. The collected product is then cryopreserved in a controlled-rate freezer.
Advantages:
⦁ Allows for the isolation of large quantities of Mononuclear Cells from a single donor.
Cell Type:
Leukopaks; Mononuclear Cells
Species:
Human
Cell and Tissue Source:
Peripheral Blood
Donor Status:
Normal
Scientific Resources
Product Documentation
Document Type
Product Name
Catalog #
Lot #
Language
200-0130, 200-0131, 200-0132
All
Educational Materials
(1)Product Applications
This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.
Research Area
Workflow Stages for
Workflow Stages
PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. FOR ADDITIONAL INFORMATION ON QUALITY AT STEMCELL, REFER TO WWW.STEMCELL.COM/COMPLIANCE.